These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25312956)

  • 1. Transgenic expression of CXCR3 on T cells enhances susceptibility to cutaneous Leishmania major infection by inhibiting monocyte maturation and promoting a Th2 response.
    Oghumu S; Stock JC; Varikuti S; Dong R; Terrazas C; Edwards JA; Rappleye CA; Holovatyk A; Sharpe A; Satoskar AR
    Infect Immun; 2015 Jan; 83(1):67-76. PubMed ID: 25312956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cells from Leishmania major-susceptible BALB/c mice have a defect in efficiently up-regulating CXCR3 upon activation.
    Barbi J; Brombacher F; Satoskar AR
    J Immunol; 2008 Oct; 181(7):4613-20. PubMed ID: 18802063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-leishmania effector functions of CD4+ Th1 cells and early events instructing Th2 cell development and susceptibility to Leishmania major in BALB/c mice.
    Louis JA; Conceiçao-Silva F; Himmelrich H; Tacchini-Cottier F; Launois P
    Adv Exp Med Biol; 1998; 452():53-60. PubMed ID: 9889959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
    Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G
    Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-12Rbeta2-deficient mice of a genetically resistant background are susceptible to Leishmania major infection and develop a parasite-specific Th2 immune response.
    Chakir H; Campos-Neto A; Mojibian M; Webb JR
    Microbes Infect; 2003 Apr; 5(4):241-9. PubMed ID: 12706437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR3-/- mice mount an efficient Th1 response but fail to control Leishmania major infection.
    Rosas LE; Barbi J; Lu B; Fujiwara Y; Gerard C; Sanders VM; Satoskar AR
    Eur J Immunol; 2005 Feb; 35(2):515-23. PubMed ID: 15668916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine.
    Schwarz T; Remer KA; Nahrendorf W; Masic A; Siewe L; Müller W; Roers A; Moll H
    PLoS Pathog; 2013; 9(6):e1003476. PubMed ID: 23825956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-4-independent acceleration of cutaneous leishmaniasis in susceptible BALB/c mice following treatment with anti-CTLA4 antibody.
    Heinzel FP; Maier RA
    Infect Immun; 1999 Dec; 67(12):6454-60. PubMed ID: 10569763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CC chemokine receptor 1 enhances susceptibility to Leishmania major during early phase of infection.
    Rodriguez-Sosa M; Rosas LE; Terrazas LI; Lu B; Gerard C; Satoskar AR
    Immunol Cell Biol; 2003 Apr; 81(2):114-20. PubMed ID: 12631234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4+CD25+ T cells.
    Aseffa A; Gumy A; Launois P; MacDonald HR; Louis JA; Tacchini-Cottier F
    J Immunol; 2002 Sep; 169(6):3232-41. PubMed ID: 12218142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility to Leishmania major in IL-4 transgenic mice is not correlated with the lack of a Th1 immune response.
    Erb KJ; Blank C; Moll H
    Immunol Cell Biol; 1996 Jun; 74(3):239-44. PubMed ID: 8799723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
    Halliday A; Bates PA; Chance ML; Taylor MJ
    Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response.
    Muraille E; De Trez C; Brait M; De Baetselier P; Leo O; Carlier Y
    J Immunol; 2003 Apr; 170(8):4237-41. PubMed ID: 12682257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunomodulatory function for neutrophils during the induction of a CD4+ Th2 response in BALB/c mice infected with Leishmania major.
    Tacchini-Cottier F; Zweifel C; Belkaid Y; Mukankundiye C; Vasei M; Launois P; Milon G; Louis JA
    J Immunol; 2000 Sep; 165(5):2628-36. PubMed ID: 10946291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BALB/c mice bearing a transgenic IL-12 receptor beta 2 gene exhibit a nonhealing phenotype to Leishmania major infection despite intact IL-12 signaling.
    Nishikomori R; Gurunathan S; Nishikomori K; Strober W
    J Immunol; 2001 Jun; 166(11):6776-83. PubMed ID: 11359836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice.
    Lopez Kostka S; Dinges S; Griewank K; Iwakura Y; Udey MC; von Stebut E
    J Immunol; 2009 Mar; 182(5):3039-46. PubMed ID: 19234200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA155 Plays a Critical Role in the Pathogenesis of Cutaneous Leishmania major Infection by Promoting a Th2 Response and Attenuating Dendritic Cell Activity.
    Varikuti S; Verma C; Natarajan G; Oghumu S; Satoskar AR
    Am J Pathol; 2021 May; 191(5):809-816. PubMed ID: 33539779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic T cell-specific expression of CXCR3 enhances splenic and hepatic T cell accumulation but does not affect the outcome of visceral leishmaniasis.
    Varikuti S; Natarajan G; Oghumu S; Sperling RH; Moretti E; Stock J; Papenfuss TL; Satoskar AR
    Cell Immunol; 2016 Nov; 309():61-68. PubMed ID: 27614845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.
    Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F
    PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ox40L-Ox40 pathway plays distinct roles in regulating Th2 responses but does not determine outcome of cutaneous leishmaniasis caused by Leishmania mexicana and Leishmania major.
    Tuladhar R; Oghumu S; Dong R; Peterson A; Sharpe AH; Satoskar AR
    Exp Parasitol; 2015 Jan; 148():49-55. PubMed ID: 25447125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.